Regeneron Pharmaceuticals Market Sentiment

Regeneron Pharmaceuticals Inc

REGNNASDAQ

$853.20

9.731.15%

Últ. Act.: Sep 3, 4:35 PM

Panorámica general Noticias Previsión de beneficios Eventos Precios objetivo FinanzasSentimientoPropiedad Dividendos Comparar Opciones Informe de acciones

Regeneron Pharmaceuticals Market Sentiment

Market sentiment signals for Regeneron Pharmaceuticals (REGN): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 2.5% short float

Options Flow— N/A

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

31 analysts

Options Flow (P/C)

—

Avg Consensus PT

$797

-6.6%

Highest Price Target

$1030

+20.7%

Guggenheim

Lowest Price Target

$185

-78.3%

Benchmark

Short Interest

2.5%

Declining — Bullish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Aug 17, 2026	Leerink Partners	David Risinger—	-3.4%	$641 → $824	Maintained	Market Perform
Aug 3, 2026	Citigroup	Geoff Meacham—	-13.3%	$700 → $740	Maintained	Neutral
Aug 3, 2026	Guggenheim	Brad Canino—	+20.7%	$1000 → $1030	Maintained	Buy
Jul 31, 2026	RBC Capital	Brian Abrahams—	-13.6%	$696 → $737	Maintained	Sector Perform
Jul 31, 2026	Morgan Stanley	Matthew Harrison—	-11.2%	$730 → $758	Maintained	Equal-Weight
Jul 31, 2026	Cantor Fitzgerald	Carter Gould—	-6.8%	$750 → $795	Maintained	Overweight
Jul 31, 2026	Wells Fargo	Mohit Bansal—	-12.1%	$700 → $750	Maintained	Equal-Weight
Jul 31, 2026	Truist Securities	Gregory Renza—	-9.5%	$769 → $772	Maintained	Buy
Jul 21, 2026	Guggenheim	Brad Canino—	+17.2%	$995 → $1000	Maintained	Buy
Jul 9, 2026	Piper Sandler	Biren Amin—	+0.1%	$855 → $854	Maintained	Overweight
Jul 8, 2026	Morgan Stanley	Matthew Harrison—	-14.4%	$788 → $730	Maintained	Equal-Weight
Jul 7, 2026	RBC Capital	Brian Abrahams—	-18.4%	$707 → $696	Maintained	Sector Perform
Jul 7, 2026	Truist Securities	Gregory Renza—	-9.9%	$778 → $769	Maintained	Buy
Jul 7, 2026	Benchmark	Robert Wasserman—	-78.3%	$185	Upgrade	Hold→Buy
Jul 6, 2026	HSBC	Rajesh Kumar—	+3.1%	$990 → $880	Maintained	Buy
Jul 6, 2026	Cantor Fitzgerald	Carter Gould—	-12.1%	$785 → $750	Maintained	Overweight
May 19, 2026	Canaccord Genuity	John Newman—	+2.6%	$1057 → $875	Maintained	Buy
May 18, 2026	BMO Capital	Evan David Seigerman—	-14.4%	$900 → $730	Maintained	Outperform
May 18, 2026	Truist Securities	Gregory Renza—	-8.8%	$796 → $778	Maintained	Buy
May 18, 2026	JP Morgan	Chris Schott—	-0.4%	$950 → $850	Maintained	Overweight
May 18, 2026	Piper Sandler	Biren Amin—	+0.2%	$875 → $855	Maintained	Overweight
May 18, 2026	Wells Fargo	Mohit Bansal—	-18.0%	$800 → $700	Maintained	Equal-Weight
May 18, 2026	RBC Capital	Brian Abrahams—	-17.1%	$762 → $707	Maintained	Sector Perform
May 18, 2026	Citigroup	Geoff Meacham—	-18.0%	$900 → $700	Downgrade	Buy→Neutral
May 18, 2026	Leerink Partners	Andrew Berens—	-24.9%	$792 → $641	Downgrade	Outperform→Market Perform